Cheryl Guttman is a medical writer based in Deerfield, Ill.
GA therapy demonstrates continuous, sustained effects of pegcetacoplan over time
Physician offers "real talk" on pros and cons that offers surgeons and patients decision-making insights.
Study backs viability of VR paradigm for orientation, mobility testing
According to investigators, the virtual reality option could overcome hurdles associated with reliance on a physical course.
Therapy shows efficacy, durable benefit, favorable safety profile
Triamcinolone acetonide injection approved for treatment of macular edema.
Varenicline nasal spray approved as a treatment for dry eye disease
Product stimulates basal tear production, restores tear film homeostasis, and relieves symptoms.
Expert insights: Flares of dry eye disease
Timely diagnosis and successful intervention are key to successful treatment.
Ophthalmology Foundation focuses on mission of vision
Organization looks to improve global eye care through ophthalmic education.
Detailing consequences of Demodex blepharitis
Symptomatic, psychosocial burdens in participants .
Maximizing CXL effectiveness
Ex vivo experiment identifies potential benefit for supplementary oxygen.
Research: Treatment targets steroid-induced OHT
Measurements from multiple studies show benefits of rho-kinase inhibition.
DME trial results are positive for intravitreal integrin antagonist
Option has a broader biologic effect for patients.
Reducing post-cataract surgery endophthalmitis: Investigators focus on therapeutic regimen
Findings from retrospective study support intraoperative cefuroxime irrigation.
Refractive surgeons report boost in patient interest during the COVID-19 era
Patients are serious about procedure and ready to move forward.
Gene therapy heralds new era for inherited retinal diseases
Physician offers patient counseling pearls for selected retinal diseases.
Pearls for optimizing patient outcomes of macular surgery
Early clinical experience with next-generation lens
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.
Do you 'need' or just 'want' that new diagnostic imaging device?
Physicians should evaluate which options best meet the needs of their practices.
Investigators find genetic factors may influence diabetic eye disease
Baseline diabetic retinopathy severity is an important predictor of its progression in patients.
Disparities in care of retinal detachments
Women 34% less likely to receive retinal detachment repair.
Expert on IFIS offers practical pearls for success
Cataract surgeons must consider medication history as part of preoperative evaluation.
Studies explore pharmacological approaches to cataract prophylaxis, treatment
Investigators find options could prove to be alternatives to surgical management.
PANORAMA trial targets NPDR
Analysis finds drug is broadly effective for reducing diabetic retinopathy severity.
Finding clinical equivalence of biosimilar, reference ranibizumab
Investigators find no clinically relevant differences in safety profiles.
Study: Innovative dexamethasone formulation shows efficacy, safety
Once-daily corticosteroid treats pain, inflammation after surgery.
Investigators explore pathogenic cytokines as biomarkers for DME
BIGH3 is an extracellular matrix protein that can act in an autocrine, paracrine manner.
Zeroing in on dry eye treatment for patients with cataracts
Study supports preoperative ocular surface optimization with artificial tears.
Pearls for selecting a syringe for intravitreal injection
All syringes used for intravitreal injections have pros and cons. Some recently marketed and forthcoming products are coming closer to meeting “ideal” criteria.
Investigators study home-based monitoring for exudative AMD
Novel OCT system with AI-based image analysis holds promise.
Investigators challenge IOL power calculations
Study finds imaging-based formulas are less accurate in post-myopic LASIK eyes.
Teleretinal screening fails to do double duty for detecting glaucoma, cataracts
Programs use detection and treatment to ease burden of eye disease.
Antihyperglycemic drug linked to reduced risk of new onset AMD
Research could lead to a novel therapeutic strategy for blinding disease
2 Clarke Drive Cranbury, NJ 08512